Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dapsone in rheumatoid arthritis

D J Chang1, M Lamothe, R M Stevens

  • 1Division of Rheumatology and Connective Tissue Research, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School 08903-0019, USA.

Seminars in Arthritis and Rheumatism
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cryptosporidiosis after treatment with fingolimod: a case report and pharmacovigilance review.

BMC infectious diseases·2020
Same author

Patient experience in systemic lupus erythematosus: development of novel patient-reported symptom and patient-reported impact measures.

Journal of patient-reported outcomes·2018
Same author

Patient safety ward round checklist via an electronic app: implications for harm prevention.

Irish journal of medical science·2017
Same author

History rather than hybridization determines population structure and adaptation in Populus balsamifera.

Journal of evolutionary biology·2017
Same author

Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USA.

Lupus science & medicine·2016
Same author

Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease.

Alimentary pharmacology & therapeutics·2015

Dapsone demonstrates effectiveness in managing rheumatoid arthritis, proving superior to placebo and comparable to other treatments. Careful monitoring is essential due to potential side effects like hemolytic anemia.

Area of Science:

  • Rheumatology
  • Pharmacology

Background:

  • Dapsone, a synthetic sulfone, has historical uses in treating leprosy and dermatitis herpetiformis.
  • Recent trials indicate dapsone's efficacy in rheumatoid arthritis management, outperforming placebo and matching chloroquine/hydroxychloroquine.

Observation:

  • The anti-inflammatory mechanism of dapsone in rheumatoid arthritis involves neutrophil modulation.
  • Case studies highlight successful dapsone treatment in advanced rheumatoid arthritis patients unresponsive to other therapies.

Findings:

  • Dapsone is a viable second-line treatment for rheumatoid arthritis.
  • Hemolytic anemia and methemoglobinemia are key dose-limiting side effects requiring careful management.

Implications:

  • Dapsone offers a valuable therapeutic option for rheumatoid arthritis patients.

Related Experiment Videos

  • Further research into dapsone's anti-inflammatory pathways and side effect mitigation is warranted.